Upcoming Webinars

Points to Consider When Defining a Microbial Control Strategy for Individualized ATMPs

Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project at Roche
05th April 2023

Contamination Control Challenges Facing Cell Therapy Facilities

Presented by Conor McMorrow, Aseptic Lead, Cell Therapy at Takeda at Félix Montero-Julian, Scientific Director of Pharma Quality Control at bioMérieux
17th April 2023

GMP Implementation of Continuous Manufacturing: A case study

Presented by Neil Soice, Executive Director, Drug Substance Technologies at Amgen, Inc. and Michael Phillips, BioContinuum™ Platform Director at Merck
18th April 2023

Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture: Updates from a CDER Microbiologist’s Perspective

Presented by Dr John Metcalfe, Senior Pharmaceutical Quality Assessor at FDA and Dr. Doug Botkin, Technology and Market Development Manager at Charles River Laboratories
19th April 2023

Stabilising The Biologics Supply Chain with Blockchain

Presented by Alexandru Popa, Associate Director, Blockchain for Pharma Supply Chain at MSD
20th April 2023

Challenges And Opportunities Of Continuous Bioprocessing And Risk Management

Presented by Sethu Madhavan, Global Head of Insulin Operations at Biocon Biologics
27th April 2023

Trends and Future of Pharmaceutical Continuous Manufacturing

Presented by Lawrence De Belder, Continuous Manufacturing Practice Lead at Pharmatech Associates, Inc. and Jan Vogeleer, Managing Director at Fette Compacting
27th April 2023

Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors

Presented by Ashish Saksule, Principal Scientist, Vector Core Lead at Vertex Pharmaceuticals and Dr Alejandro Becerra, Principal Applications Scientist and Global Purification Technical Lead at Thermo Fisher Scientific
10th May 2023

Ruggedness and Robustness in Nitrosamine Analysis from Pharmaceutical Elastomers

Presented by Jason Creasey, Managing Director at Maven E&L Ltd
23rd May 2023

Capabilities Development for Sterile Manufacturing

Presented by Dr Mauro Giusti, Senior Director, Site External Network at Eli Lilly & President, PDA Italy Chapter
07th September 2023

Best Practices of Downstream Protein Purification and Product Concentration

Presented by Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Senior Director at Biocon Biologics
12th September 2023

De-bottlenecking Challenges in Large Scale Viral Vector Manufacturing for Gene Therapy Applications

Presented by Presented by Prateek Gupta, PhD Senior Vice President, Process Development & MSAT at Stelis Biopharma
13th September 2023

Considerations For Sterility Test Methods When Working With CDMOs

Presented by Miriam Guest, Associate Principal Microbiologist, New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK, Anne Weeks, Senior Field Marketing Manager, at Merck and Chris Berridge, Global Technical Consultant, Bio-Decontamination Specialist at Ecolab
14th September 2023

Deploying Modeling & Simulation to Enable Advanced Process Monitoring & Control

Presented by Johannes Scheiblauer, Associate Scientific Fellow for Digital CMC at Takeda
18th September 2023

The Road to Digitalisation of a Research Lab

Presented by Steffie Eggermont, Upstream Process Sciences team at UCB
21st September 2023

Evaluation of Optimal Extraction Conditions for Polypropylene, PBT Resins, and Chlorobutyl Rubber Elastomer – Using a Variety of Solvents and Extraction Conditions

Presented by Daniel Norwood, Principal Consultant at Feinberg Norwood & Associates Pharma Consulting
04th October 2023